论文信息 - Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats. - 字舞流文

Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats.

N. Semeraro | M. Colucci | L. Sardella | F. Calanni | M. Barbanti

[1] N. Semeraro,et al. Desmin 370, a Low Molecular Weight Dermatan Sulfate, Reduces the Weight of Preformed Thrombi in Rats Made Afibrinogenemic by Ancrod , 1995, Thrombosis and Haemostasis.

[2] B. Bouma,et al. Fibrinolytic Activity in Blood Is Distributed over a Cellular and the Plasma Fraction which Can Be Modulated Separately , 1994, Thrombosis and Haemostasis.

[3] N. Semeraro,et al. Therapeutic Effect of a Low Molecular Weight Dermatan Sulphate (Desmin 370) in Rat Venous Thrombosis - Evidence for an Anticoagulant-Independent Mechanism , 1993, Thrombosis and Haemostasis.

[4] P. Holvoet,et al. Experimental Pulmonary Embolus in the Rat: A New in vivo Model to Test Thrombolytic Drugs , 1988, Journal of cardiovascular pharmacology.

[5] D. Tollefsen,et al. Activation of heparin cofactor II by dermatan sulfate. , 1983, The Journal of biological chemistry.

[6] L. Moroz,et al. A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin. , 1975, Blood.